VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,515 | -12.5% | 93,452 | -2.1% | 0.00% | 0.0% |
| Q2 2023 | $2,875 | +12.4% | 95,481 | +20.7% | 0.00% | +33.3% |
| Q1 2023 | $2,558 | +12.8% | 79,084 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,267 | -99.9% | 79,084 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $2,390,000 | +132.7% | 99,084 | +164.2% | 0.00% | +200.0% |
| Q2 2022 | $1,027,000 | +24.3% | 37,497 | +74.0% | 0.00% | 0.0% |
| Q1 2022 | $826,000 | -59.3% | 21,551 | -66.0% | 0.00% | -50.0% |
| Q4 2021 | $2,030,000 | +1281.0% | 63,371 | +1167.4% | 0.00% | – |
| Q3 2021 | $147,000 | -13.5% | 5,000 | 0.0% | 0.00% | – |
| Q2 2021 | $170,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |